C3.ai, Inc. (AI) Current Ratio
- Current ratio · latest quarter: Value 6.16×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.16× | Current assets / current liabilities. $770.17M ÷ $125.12M ≈ 6.16× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 770.17M USD | Assets, Current |
| Current obligations | 125.12M USD | Liabilities, Current |
| Cash and equivalents | 136.44M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 514.63M USD | Marketable Securities, Current |
| Customer receivables | 94.57M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 8.74M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $770.17M | $125.12M | $136.44M | $514.63M | $94.57M | (m) | $8.74M | (m) | 6.16× |
| 2026-04-30 | $707.96M | $106.57M | $66.20M | $509.25M | $100.55M | (m) | $5.51M | (m) | 6.64× |
| 2026-01-31 | $782.70M | $118.94M | $88.85M | $533.08M | $123.57M | (m) | $18.15M | (m) | 6.58× |
| 2025-10-31 | $845.90M | $130.82M | $103.20M | $571.83M | $136.06M | (m) | $35.94M | (m) | 6.47× |
| 2025-07-31 | $851.11M | $111.29M | $80.94M | $630.96M | $113.92M | (m) | $12.08M | (m) | 7.65× |
| 2025-04-30 | $904.25M | $131.88M | $164.36M | $578.33M | $137.23M | (m) | $15.16M | (m) | 6.86× |
| 2025-01-31 | $930.90M | $138.05M | $125.09M | $599.23M | $180.36M | (m) | $28.74M | (m) | 6.74× |
| 2024-10-31 | $917.82M | $122.01M | $121.27M | $609.10M | $159.99M | (m) | $20.61M | (m) | 7.52× |
| 2024-07-31 | $926.41M | $117.93M | $133.82M | $628.72M | $140.07M | (m) | $31.61M | (m) | 7.86× |
| 2024-04-30 | $904.39M | $102.33M | $167.15M | $583.22M | $130.06M | (m) | $11.32M | (m) | 8.84× |
| 2024-01-31 | $926.03M | $109.18M | $114.56M | $608.76M | $173.48M | (m) | $19.84M | (m) | 8.48× |
| 2023-10-31 | $931.08M | $114.15M | $149.01M | $613.26M | $143.15M | (m) | $25.74M | (m) | 8.16× |
| 2023-07-31 | $894.79M | $110.71M | $206.44M | (m) | $122.57M | (m) | $26.89M | (m) | 8.08× |
| 2023-04-30 | $888.88M | $136.04M | $284.83M | $446.15M | $134.59M | (m) | $24.61M | (m) | 6.53× |
| 2023-01-31 | $946.51M | $123.61M | $311.14M | (m) | $143.68M | (m) | $19.99M | (m) | 7.66× |
| 2022-10-31 | $960.07M | $118.66M | $277.62M | (m) | $94.76M | (m) | $30.66M | (m) | 8.09× |
| 2022-07-31 | $1.01B | $131.25M | $221.88M | (m) | $81.30M | (m) | $40.75M | (m) | 7.67× |
| 2022-04-30 | $1.06B | $150.17M | $339.53M | (m) | $80.27M | (m) | $54.22M | (m) | 7.06× |
| 2022-01-31 | $1.06B | $129.19M | $204.53M | (m) | $68.18M | (m) | $14.48M | (m) | 8.22× |
| 2021-10-31 | $1.02B | $132.18M | $167.44M | (m) | $27.17M | (m) | $10.13M | (m) | 7.69× |
| 2021-07-31 | $1.17B | $140.13M | $273.78M | (m) | $55.83M | (m) | $10.05M | (m) | 8.33× |
| 2021-04-30 | $1.17B | $124.48M | $115.36M | (m) | $65.46M | (m) | $12.07M | (m) | 9.42× |
| 2021-01-31 | $1.17B | $104.10M | $960.12M | (m) | $30.23M | (m) | $12.61M | (m) | 11.21× |
| 2020-04-30 | $281.20M | $81.04M | $33.10M | (m) | $30.83M | (m) | $4.73M | (m) | 3.47× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.